The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
Alzheimer’s disease
Morris water maze
apolipoproteins E
brain-derived neurotrophic factor
entorhinal cortex
episodic memory
gene polymorphism
magnetic resonance imaging
mild cognitive impairment
spatial navigation
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
16
12
2020
pubmed:
17
12
2020
medline:
30
9
2021
Statut:
ppublish
Résumé
The apolipoprotein E (APOE) ɛ4 allele is associated with episodic memory and spatial navigation deficits. The brain-derived neurotrophic factor (BDNF) Met allele may further worsen memory impairment in APOEɛ4 carriers but its role in APOEɛ4-related spatial navigation deficits has not been established. We examined influence of APOE and BDNF Val66Met polymorphism combination on spatial navigation and volumes of selected navigation-related brain regions in cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (aMCI). 187 participants (aMCI [n = 116] and CU [n = 71]) from the Czech Brain Aging Study were stratified based on APOE and BDNF Val66Met polymorphisms into four groups: ɛ4-/BDNFVal/Val, ɛ4-/BDNFMet, ɛ4+/BDNFVal/Val, and ɛ4+/BDNFMet. The participants underwent comprehensive neuropsychological examination, brain MRI, and spatial navigation testing of egocentric, allocentric, and allocentric delayed navigation in a real-space human analogue of the Morris water maze. Among the aMCI participants, the ɛ4+/BDNFMet group had the least accurate egocentric navigation performance (p < 0.05) and lower verbal memory performance than the ɛ4-/BDNFVal/Val group (p = 0.007). The ɛ4+/BDNFMet group had smaller hippocampal and entorhinal cortical volumes than the ɛ4-/BDNFVal/Val (p≤0.019) and ɛ4-/BDNFMet (p≤0.020) groups. Among the CU participants, the ɛ4+/BDNFMet group had less accurate allocentric and allocentric delayed navigation performance than the ɛ4-/BDNFVal/Val group (p < 0.05). The combination of APOEɛ4 and BDNF Met polymorphisms is associated with more pronounced egocentric navigation impairment and atrophy of the medial temporal lobe regions in individuals with aMCI and less accurate allocentric navigation in CU older adults.
Sections du résumé
BACKGROUND
The apolipoprotein E (APOE) ɛ4 allele is associated with episodic memory and spatial navigation deficits. The brain-derived neurotrophic factor (BDNF) Met allele may further worsen memory impairment in APOEɛ4 carriers but its role in APOEɛ4-related spatial navigation deficits has not been established.
OBJECTIVE
We examined influence of APOE and BDNF Val66Met polymorphism combination on spatial navigation and volumes of selected navigation-related brain regions in cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (aMCI).
METHODS
187 participants (aMCI [n = 116] and CU [n = 71]) from the Czech Brain Aging Study were stratified based on APOE and BDNF Val66Met polymorphisms into four groups: ɛ4-/BDNFVal/Val, ɛ4-/BDNFMet, ɛ4+/BDNFVal/Val, and ɛ4+/BDNFMet. The participants underwent comprehensive neuropsychological examination, brain MRI, and spatial navigation testing of egocentric, allocentric, and allocentric delayed navigation in a real-space human analogue of the Morris water maze.
RESULTS
Among the aMCI participants, the ɛ4+/BDNFMet group had the least accurate egocentric navigation performance (p < 0.05) and lower verbal memory performance than the ɛ4-/BDNFVal/Val group (p = 0.007). The ɛ4+/BDNFMet group had smaller hippocampal and entorhinal cortical volumes than the ɛ4-/BDNFVal/Val (p≤0.019) and ɛ4-/BDNFMet (p≤0.020) groups. Among the CU participants, the ɛ4+/BDNFMet group had less accurate allocentric and allocentric delayed navigation performance than the ɛ4-/BDNFVal/Val group (p < 0.05).
CONCLUSION
The combination of APOEɛ4 and BDNF Met polymorphisms is associated with more pronounced egocentric navigation impairment and atrophy of the medial temporal lobe regions in individuals with aMCI and less accurate allocentric navigation in CU older adults.
Identifiants
pubmed: 33325388
pii: JAD200615
doi: 10.3233/JAD-200615
pmc: PMC7836052
doi:
Substances chimiques
Apolipoprotein E4
0
Brain-Derived Neurotrophic Factor
0
BDNF protein, human
7171WSG8A2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1473-1492Références
Neurodegener Dis. 2011;8(4):169-77
pubmed: 21124005
Nat Rev Neurol. 2018 Aug;14(8):496-506
pubmed: 29980763
Mol Psychiatry. 2021 Feb;26(2):614-628
pubmed: 30899092
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2590-4
pubmed: 22308496
J Lipid Res. 1990 Mar;31(3):545-8
pubmed: 2341813
Neurochem Int. 2011 Aug;59(1):1-4
pubmed: 21672569
Alzheimers Dement. 2018 Jul;14(7):913-924
pubmed: 29601787
Neurodegener Dis. 2010;7(1-3):148-52
pubmed: 20197695
Alzheimers Dement. 2011 Jul;7(4):456-65
pubmed: 21784354
Ann Neurol. 2000 Apr;47(4):430-9
pubmed: 10762153
Neurobiol Aging. 2013 Nov;34(11):2457-64
pubmed: 23769397
PLoS One. 2014 Jan 27;9(1):e86498
pubmed: 24475133
BMJ Open. 2019 Dec 18;9(12):e030379
pubmed: 31857299
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Neurobiol Aging. 2017 Mar;51:67-70
pubmed: 28039765
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72
pubmed: 18003925
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Alzheimers Dis. 2020;73(1):247-257
pubmed: 31771052
Hum Brain Mapp. 2017 Jan;38(1):271-282
pubmed: 27593520
Neuropsychology. 2014 Sep;28(5):676-684
pubmed: 24749727
PLoS One. 2016 Apr 11;11(4):e0152901
pubmed: 27065111
J Alzheimers Dis. 2017;59(3):883-892
pubmed: 28697554
Nat Rev Neurosci. 2018 Feb;19(2):63-80
pubmed: 29321682
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
J Nucl Med. 2000 Jul;41(7):1155-62
pubmed: 10914904
J Alzheimers Dis. 2013;33(2):507-15
pubmed: 23247007
Neurobiol Aging. 2012 Jan;33(1):202.e15-22
pubmed: 20832911
Neuropharmacology. 2014 Jan;76 Pt C:603-9
pubmed: 23664813
Behav Brain Res. 2016 Jul 1;307:150-8
pubmed: 27038766
Arch Gen Psychiatry. 2011 Feb;68(2):198-206
pubmed: 21300947
Neuroreport. 1996 Nov 25;7(18):2925-8
pubmed: 9116211
N Engl J Med. 2009 Jul 16;361(3):255-63
pubmed: 19605830
Neurosci Res. 2006 Aug;55(4):361-9
pubmed: 16735070
Brain Res Bull. 2010 Jan 15;81(1):61-5
pubmed: 19589373
N Engl J Med. 1996 Mar 21;334(12):752-8
pubmed: 8592548
Aging Dis. 2015 Oct 01;6(5):331-41
pubmed: 26425388
Elife. 2019 Apr 30;8:
pubmed: 31038453
Alzheimers Dement. 2012 Sep;8(5):381-8
pubmed: 22863908
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
J Alzheimers Dis. 2016 Feb 9;52(1):77-90
pubmed: 26967209
Neurology. 2017 May 30;88(22):2098-2106
pubmed: 28468845
Arch Neurol. 2001 Sep;58(9):1395-402
pubmed: 11559310
J Neurosci. 2014 Dec 3;34(49):16207-19
pubmed: 25471562
Neuropharmacology. 2014 Jan;76 Pt C:664-76
pubmed: 23831365
Science. 1998 May 8;280(5365):921-4
pubmed: 9572740
JAMA. 1995 Apr 26;273(16):1274-8
pubmed: 7646655
Neurology. 1992 Jan;42(1):183-8
pubmed: 1734300
Neurology. 2017 Sep 5;89(10):1028-1034
pubmed: 28794245
Front Behav Neurosci. 2014 Mar 17;8:89
pubmed: 24672452
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4042-7
pubmed: 17360474
J Alzheimers Dis. 2012;30(4):935-42
pubmed: 22475794
Lancet. 1996 Jul 13;348(9020):90-3
pubmed: 8676723
Brain Sci. 2020 Mar 25;10(4):
pubmed: 32218234
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):101-106
pubmed: 29578861
Neurosci Biobehav Rev. 2012 Oct;36(9):2165-77
pubmed: 22813992
Cereb Cortex. 2004 Jan;14(1):11-22
pubmed: 14654453
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8299-302
pubmed: 15932949
Psychopharmacol Bull. 1988;24(4):709-11
pubmed: 3249773
Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):958-69
pubmed: 23065961
PLoS One. 2012;7(6):e37777
pubmed: 22719849
J Neurosci. 2004 Nov 10;24(45):10099-102
pubmed: 15537879
Neurobiol Aging. 2010 Jun;31(6):901-9
pubmed: 18789830
Neurodegener Dis. 2012;10(1-4):153-7
pubmed: 22205134
Neuroscience. 2007 Jun 15;147(1):6-17
pubmed: 17509769
Nature. 2003 Sep 11;425(6954):184-8
pubmed: 12968182
Front Cell Neurosci. 2018 Dec 17;12:493
pubmed: 30618640
Pharmacogenomics J. 2010 Oct;10(5):375-84
pubmed: 20029386
J Neurosci. 2003 Jul 30;23(17):6690-4
pubmed: 12890761
Neurobiol Aging. 2015 Jun;36(6):2024-33
pubmed: 25862420
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Behav Brain Res. 2014 Sep 1;271:309-15
pubmed: 24946073
Eur J Neurosci. 2011 Mar;33(5):968-77
pubmed: 21255124
Neurobiol Aging. 2018 Apr;64:107-115
pubmed: 29358117
Brain. 2003 Sep;126(Pt 9):1955-67
pubmed: 12821520
Front Aging Neurosci. 2013 Dec 19;5:94
pubmed: 24391585
Cell. 2003 Jan 24;112(2):257-69
pubmed: 12553913
Hippocampus. 2013 Oct;23(10):919-30
pubmed: 23733450
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42
pubmed: 10811879
Cold Spring Harb Perspect Biol. 2015 Feb 02;7(2):a021808
pubmed: 25646382
Behav Brain Res. 2009 Sep 14;202(2):252-9
pubmed: 19463709
Curr Alzheimer Res. 2018;15(3):219-228
pubmed: 29165083
Arch Neurol. 2000 Jun;57(6):846-51
pubmed: 10867782
J Neurosci. 2016 Jun 15;36(24):6371-81
pubmed: 27307227
Mol Psychiatry. 2015 Nov;20(11):1322-8
pubmed: 25288138
J Neurol Sci. 2015 Dec 15;359(1-2):430-7
pubmed: 26478129
Neurobiol Aging. 2016 Mar;39:165-73
pubmed: 26923413
Neuropsychologia. 2011 Feb;49(3):518-27
pubmed: 21185847